Yahoo España Búsqueda web

Search results

  1. Hace 4 días · Las estrellas del equipo durante este período han sido Tatsunori Hara, que es el manager actual; Hideki Matsui, quien fue el bateador de poder más dominante de la liga entre 1993 y 2002; y el lanzador Koji Uehara, quien se fue a las Grandes Ligas luego de culminada la temporada 2008 y tuvo una exitosa carrera a ese nivel.

  2. www.koji-uehara.net › allkoji-uehara.net

    Hace 2 días · 松坂世代No. 1の最強打者はなぜ消えた?. 原因は甲子園の悲劇!?元PL学園・上重聡さんが語る松坂世代のライバル達【上重だけが知る松坂大輔の素顔】【新垣・杉内・村田…全員エゲツない】【①/3】. 皆さん、宜しくお願いします!! 上原浩治オフィシャル ...

  3. Hace 4 días · In a landmark decision, Japan ’s Supreme Court ordered the government Wednesday to pay suitable compensation to about a dozen victims who were forcibly sterilized under a now-defunct Eugenics ...

  4. Hace 3 días · Koji Takao (高雄コウジ, Takao Kōji) is one of Wille's engineers and is responsible for the engine ignition sequence of the Wunder ship. Koji presents himself as a man of robust build; he is balding, and has a goatee and a black mustache.

  5. Hace 1 día · There is little evidence regarding radiation dose perturbation caused by the self-expandable metallic stents (SEMSs) used for transpapillary biliary decompression. We aimed to compare SEMSs with plastic stents (PSs) and clarify their dosimetric characteristics. Fifteen SEMSs (10 braided and 5 lasercut type) and six PSs (diameter: 2.3–3.3 mm) were inserted into a water-equivalent solid ...

  6. Hace 2 días · Hands-down the single most beautiful lane in all of Kyoto, Ishibei-koji Lane is like entering another world. Isibei-koji Street Blink and you’ll miss the entrance to Ishibei-koji Lane, Kyoto’s most atmospheric pedestrian-only walkway.

  7. Hace 4 días · Nirmatrelvir (PF-07321332), a first-in-class inhibitor of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) main protease (Mpro), was developed by Pfizer under intense pressure during the pandemic to treat COVID-19. A weakness of nirmatrelvir is its limited metabolic stability, which led to the development of a combination therapy (paxlovid), involving coadministration of ...